Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 234-190-3 | CAS number: 10588-01-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- The EU RAR (2005) reports the findings of a number of published tests of cytogenicity / clastogenicity performed with Cr (VI) compounds and incorporates the findings of previous reviews by the UK Health & Safety Executive (HSE; 1989) and the UK Institute of Occupational Health (IOH, 1997). Individual studies are of varying reliability but the overall conclusion (weight of evidence) is considered to be reliable.
Cross-reference
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- other: review
- Title:
- European Union Risk Assessment Report: chromium trioxide, sodium chromate, sodium dichromate, ammonium dichromate and potassium dichromate
- Author:
- European Chemicals Bureau
- Year:
- 2 005
- Bibliographic source:
- 3rd. Priority List; Volume 53
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: Cytogenicity Study
- Principles of method if other than guideline:
- The EU RAR summarises the findings of a number of cytogenicity studies performed to various non-standard designs.
- GLP compliance:
- no
- Remarks:
- largely older, literature studies
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- Chromium trioxide
- EC Number:
- 215-607-8
- EC Name:
- Chromium trioxide
- Cas Number:
- 1333-82-0
- Molecular formula:
- CrO3
- IUPAC Name:
- Trioxochromium
- Reference substance name:
- Sodium dichromate
- EC Number:
- 234-190-3
- EC Name:
- Sodium dichromate
- Cas Number:
- 10588-01-9
- Molecular formula:
- Cr2Na2O7
- IUPAC Name:
- sodium dichromate
- Reference substance name:
- Sodium chromate
- EC Number:
- 231-889-5
- EC Name:
- Sodium chromate
- Cas Number:
- 7775-11-3
- Molecular formula:
- CrH2O4.2Na
- IUPAC Name:
- disodium dioxido(dioxo)chromium
- Reference substance name:
- Potassium dichromate
- EC Number:
- 231-906-6
- EC Name:
- Potassium dichromate
- Cas Number:
- 7778-50-9
- Molecular formula:
- Cr2H2O7.2K
- IUPAC Name:
- potassium dichromate
- Details on test material:
- No further details are reported
Constituent 1
Constituent 2
Constituent 3
Constituent 4
Method
- Target gene:
- Not applicable - cytogenicity / clastogenicity assays
Species / strain
- Species / strain / cell type:
- other: various
- Metabolic activation:
- with and without
- Metabolic activation system:
- various
- Test concentrations with justification for top dose:
- Various
- Vehicle / solvent:
- Not reported for individual studies
Controls
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- not specified
- True negative controls:
- not specified
- Positive controls:
- not specified
- Positive control substance:
- not specified
- Details on test system and experimental conditions:
- Not reported for individual studies
- Evaluation criteria:
- Not reported for individual studies
- Statistics:
- Not reported for individual studies
Results and discussion
Test results
- Species / strain:
- other: various
- Metabolic activation:
- with and without
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Additional information on results:
- The results of in vitro cytogenicity /clastogenicity / chromosomal aberration tests performed with the water-soluble Cr (VI) compounds in this group are invariably positive.
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
The results of in vitro cytogenicity /clastogenicity / chromosomal aberration tests performed with the water-soluble Cr (VI) compounds in this group are invariably positive.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
positive weight of evidence
The results of numerous tests performed with water-soluble Cr (VI) compounds indicate that this group of compounds is clastogenic in vitro. - Executive summary:
There is a very large body of evidence indicating that the Cr (VI) ion in solution is directly clastogenic in vitro. This activity was diminished considerably by the presence of reducing agents, in the form of tissue S9 or S12 fractions, gastric juice or reducing agents such as glutathione, ascorbate or sulphite. These all serve to reduce Cr (VI) to Cr (III) outside the cell therefore greatly reducing entry of chromium into the cell.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.